At a glance
ClinicalIndex Comparison RecordN/ACompleted· 361 enrolled
Drug / intervention
70 Gy/CGE +1 moreradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Expanded Phase II Study of Hypofractionated Dose Intense Image Guided Proton Radiation Therapy for Low and Intermediate Risk Adenocarcinoma of the Prostate
In Brief
A clinical study evaluating 70 Gy/CGE and 72.5 Gy/CGE for Prostate Cancer. Completed, enrolled 361 participants across 1 site.
Detailed Summary
The purpose of this trial is to give a shorter course (5 ½-6 weeks) of proton radiation that has as little side effects on normal bladder and rectal tissues as the usual longer course (8 weeks) of proton radiation, without decreasing the chance of killing prostate cancer cells.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJun 2011
Enrollment StartSep 2011
Primary CompletionAug 2025
TodayJul 2026
First PostedJun 7, 2011
Enrollment StartSep 1, 2011
Primary CompletionAug 1, 2025
TodayJul 2, 2026
Enrollment to primary: 13.9 yearsPosted 15.1 years ago
Interventions
70 Gy/CGEradiation
Low Risk
72.5 Gy/CGEradiation
Intermediate Risk